Valeant Pharmaceuticals Intl Inc (VRX) Soars As Debt Deal ReachedMani
Valeant Pharmaceuticals Intl Inc (VRX) obtained consent from over half of loan holders to push back regulatory filing deadlines and loosen financial conditions on the loans. The week marks a series of positive developments for the struggling drug maker and, mirroring the positive developments, Valeant shares surged $5.44, or 19% Wednesday to close at $34.17, making the latest increase the biggest one-day percentage jump since Sept. 9, 2005. Shares are up again about 7 percent today on news that it secured a commitment from loan . . .
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.